MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis.

Xu, Linrui; Wang, Faping; Luo, Fengming

Xu, Linrui; Wang, Faping; Luo, Fengming.

Afiliación

Xu L; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang F; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Luo F; Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Front Oncol ; 12: 1013299, 2022.

Article en En | MEDLINE | ID: mdl-36387098

Palabras clave

MET inhibitors; activity; meta-analysis; non-small cell lung cancer; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google